Ignite Creation Date:
2025-12-24 @ 2:48 PM
Ignite Modification Date:
2025-12-25 @ 11:51 PM
Study NCT ID:
NCT04476459
Status:
UNKNOWN
Last Update Posted:
2021-03-15
First Post:
2020-07-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL
Sponsor:
Organization: